H. Vogelsang

发表

The histopathology of coeliac disease: time for a standardized report scheme for pathologists.

G. Oberhuber, G. Granditsch, H. Vogelsang, 1999, European journal of gastroenterology & hepatology.

Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.

H. Tilg, A. Kaser, W. Petritsch, 2010, Gastroenterology.

Extracorporeal photochemotherapy in patients with steroid‐dependent Crohn’s disease: a prospective pilot study

W. Reinisch, A. Gangl, T. Waldhör, 2001, Alimentary pharmacology & therapeutics.

Findings at Helical CT–Enteroclysis in Symptomatic Patients With Crohn Disease: Correlation With Endoscopic and Surgical Findings

P. Wunderbaldinger, K. Turetschek, W. Schima, 2002, Journal of computer assisted tomography.

Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment

W. Reinisch, H. Lochs, A. Gangl, 2003, American Journal of Gastroenterology.

The value of serologic markers in indeterminate colitis: a prospective follow-up study.

P. Rutgeerts, S. Vermeire, W. Reinisch, 2003, Gastroenterology.

Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse.

S. Bakos, W. Reinisch, C. Lichtenberger, 1999 .

Clinical relevance of serum interleukin-6 in Crohn's disease: single point measurements, therapy monitoring, and prediction of clinical relapse

S. Bakos, W. Reinisch, C. Lichtenberger, 1999, American Journal of Gastroenterology.

Influence of topically and systemically active steroids on circulating leukocytes in Crohn's disease

S. Bakos, W. Reinisch, C. Lichtenberger, 1998, American Journal of Gastroenterology.

Influence of topically and systemically active steroids on circulating leukocytes in Crohn's disease.

S. Bakos, W. Reinisch, C. Lichtenberger, 1998 .

Anastomotic recurrence of Crohn’s disease after ileocolic resection: comparison of MR enteroclysis with endoscopy

K. Turetschek, W. Schima, P. Peloschek, 2008, European Radiology.

Prime and boost aerosol exposure via fog machine or shisha smoke followed by cinnamon hypersensitivity and anaphylaxis to spiced food

E. Leitner, F. Roth‐Walter, H. Vogelsang, 2016, The World Allergy Organization journal.

Endoscopic ultrasonography versus computed tomography in the differential diagnosis of perianorectal complications in Crohn's disease.

H. Lochs, M. Schratter, H. Vogelsang, 1993, Endoscopy.

Dynamics of occurrence of refractory coeliac disease and associated complications over 25 years

M. Trauner, F. Wrba, H. Vogelsang, 2017, Alimentary pharmacology & therapeutics.

6-Thioguanine Treatment in Inflammatory Bowel Disease: A Critical Appraisal by a European 6-TG Working Party

W. Petritsch, M. Schwab, W. Reinisch, 2006, Digestion.

Clinical presentation of venous thromboembolism in inflammatory bowel disease.

H. Tilg, A. Kaser, W. Petritsch, 2013, Journal of Crohn's & colitis.

Relationship between the use of unconventional therapies and disease-related concerns: a study of patients with inflammatory bowel disease.

G. Sachs, H. Lochs, J. Wyatt, 1996, Journal of psychosomatic research.

Prediction of Individual Serum Infliximab Concentrations in Inflammatory Bowel Disease by a Bayesian Dashboard System

D. Mould, W. Reinisch, G. Novacek, 2018, Journal of clinical pharmacology.

Screening for celiac disease: a prospective study on the value of noninvasive tests.

D. Genser, E. Penner, P. Ferenci, 1995, The American journal of gastroenterology.

Gastrointestinal permeability in celiac disease.

G. Oberhuber, H. Vogelsang, 1997, Gastroenterology.

Lack of Efficacy on Perforating Complications in Crohn’s Disease

W. Reinisch, P. Ferenci, G. Novacek, 2003 .

Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study.

D. Genser, B. Tribl, H. Vogelsang, 1995, American Journal of Gastroenterology.

NOD2/CARD15 Gene Variants Are Linked to Failure of Antibiotic Treatment in Perianal Fistulating Crohn's Disease

M. Schwab, W. Reinisch, E. Schaeffeler, 2008, The American Journal of Gastroenterology.

Assessing the Demand for Psychological Care in Chronic Diseases: Development and Validation of a Questionnaire Based on the Example of Inflammatory Bowel Disease

W. Reinisch, A. Gangl, T. Stamm, 2004, Inflammatory bowel diseases.

Celiac Diseases

G. Oberhuber, H. Vogelsang, M. Schwarzenhofer, 1999 .

In vitro Model of the Pathogenesis of Celiac Disease

G. Oberhuber, H. Vogelsang, M. Schwarzenhofer, 1998, Digestive Diseases.

Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease but not in giardiasis.

Stolte, M. Stolte, G. Oberhuber, 1996, The American journal of pathology.

ROC-king onwards: intraepithelial lymphocyte counts, distribution and role in coeliac disease mucosal interpretation

A. Moschen, G. Oberhuber, H. Vogelsang, 2017, Gut.

Acidic colonic microclimate--possible reason for false negative hydrogen breath tests.

P. Ferenci, A. Gangl, H. Vogelsang, 1988, Gut.

Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease?

W. Reinisch, A. Gangl, G. Norman, 2003, European journal of gastroenterology & hepatology.

Status of lipidsoluble antioxidants and TRAP in patients with Crohn’s disease and healthy controls

D. Genser, I. Elmadfa, H. Vogelsang, 1999, European Journal of Clinical Nutrition.

A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis.

H. Tilg, A. Kaser, P. Rutgeerts, 2003, Gut.

A randomized placebo-controlled trial of pegylated interferon alpha in active ulcerative colitis

H. Tilg, A. Kaser, P. Rutgeerts, 2003 .

Prospective evaluation of interferon-α in treatment of chronic active Crohn's disease

W. Reinisch, H. Lochs, A. Gangl, 1995, Digestive Diseases and Sciences.

Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.

W. Reinisch, S. Eichinger, G. Novacek, 2021, Inflammatory bowel diseases.

Diagnostic delay in patients with inflammatory bowel disease in Austria

T. Waldhör, G. Novacek, H. Vogelsang, 2019, Wiener klinische Wochenschrift.

Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

F. Lammert, M. Trauner, M. Mandorfer, 2013, Journal of hepatology.

Predictors of indeterminate IFN‐γ release assay in screening for latent TB in inflammatory bowel diseases

W. Reinisch, G. Novacek, H. Vogelsang, 2011, European journal of clinical investigation.

Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?

W. Reinisch, A. Gangl, H. Vogelsang, 2001, American Journal of Gastroenterology.

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

W. Reinisch, G. Novacek, H. Vogelsang, 2004, Gut.

A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens

R. Valenta, I. Swoboda, H. Vogelsang, 2013, Amino Acids.

Patients suffering from non‐IgE‐mediated cow’s milk protein intolerance cannot be diagnosed based on IgG subclass or IgA responses to milk allergens

A. Mari, H. Hochwallner, U. Schulmeister, 2011, Allergy.

An Open-Label Pilot Study of Granulocyte Colony-Stimulating Factor for the Treatment of Severe Endoscopic Postoperative Recurrence in Crohn’s Disease

W. Reinisch, A. Gangl, G. Oberhuber, 2004, Digestion.

Broadband Ultrasound Attenuation of the Calcaneus

W. Hörl, A. Gangl, S. Grampp, 1998, Acta radiologica.

Passive Smoking Increases the Risk for Intestinal Surgeries in Patients With Crohn's Disease.

W. Reinisch, G. Novacek, H. Vogelsang, 2020, Inflammatory bowel diseases.

Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF‐α inhibitors

W. Reinisch, G. Novacek, H. Vogelsang, 2012, Alimentary pharmacology & therapeutics.

Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation.

P. Ferenci, A. Gangl, H. Resch, 1995, European journal of gastroenterology & hepatology.

Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization

H. Herfarth, G. Adler, V. Gross, 2004, International Journal of Colorectal Disease.

Calcaneal ultrasound attenuation and vitamin-D-receptor genotypes in celiac disease.

W. Mayr, H. Vogelsang, E. Suk, 2000, Scandinavian journal of gastroenterology.

Influence of Helicobacter pylori infection on the phenotype of Crohn's disease

A. Püspök, T. Waldhör, C. Gasche, 1999, American Journal of Gastroenterology.

Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease

W. Reinisch, H. Vogelsang, C. Dejaco, 2003, Alimentary pharmacology & therapeutics.

Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease

G. Novacek, W. Speiser, S. Kapiotis, 1999, American Journal of Gastroenterology.

Tissue factor exposing microparticles in inflammatory bowel disease.

W. Reinisch, P. Kyrle, G. Novacek, 2013, Journal of Crohn's & colitis.

Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's disease.

P. Wunderbaldinger, K. Turetschek, W. Schima, 2005, AJR. American journal of roentgenology.

Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease.

G. Novacek, W. Speiser, S. Kapiotis, 1999 .

Crohn’s disease: prevalence, MR features, and clinical significance of enteric and colonic sinus tracts

W. Schima, Michael Weber, M. Scharitzer, 2020, European Radiology.

[Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].

H. Tilg, C. Campregher, W. Reinisch, 2013, Zeitschrift fur Gastroenterologie.

Significant association of strictures and internal fistula formation in Crohn’s disease

C. Gasche, G. Oberhuber, H. Vogelsang, 2000, Virchows Archiv.

Aberrant esophageal HLA-DR expression in a high percentage of patients with Crohn's disease.

M. Stolte, A. Chott, A. Püspök, 1999, The American journal of surgical pathology.

Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease

T. Waldhör, G. Novacek, H. Vogelsang, 2020, United European gastroenterology journal.

Comparison of enteral nutrition and drug treatment in active Crohn's disease. Results of the European Cooperative Crohn's Disease Study. IV.

M. Zeitz, H. Lochs, W. Fleig, 1991, Gastroenterology.

The efficacy and safety of either infliximab or adalimumab in 362 patients with anti‐TNF‐α naïve Crohn's disease

W. Petritsch, W. Reinisch, G. Novacek, 2016, Alimentary pharmacology & therapeutics.

Bone disease in vitamin D-deficient patients with Crohn's disease

P. Ferenci, A. Gangl, H. Resch, 1989, Digestive Diseases and Sciences.

Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study

M. Braddock, P. Rutgeerts, S. Vermeire, 2015, Inflammatory bowel diseases.

Renal insufficiency in IBD--prevalence and possible pathogenetic aspects.

W. Reinisch, G. Novacek, H. Vogelsang, 2013, Journal of Crohn's & colitis.

OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study

G. D'Haens, M. Ferrante, L. Peyrin-Biroulet, 2020 .

The Impact of Thiopurines on the Risk of Surgical Recurrence in Patients With Crohn's Disease After First Intestinal Surgery

W. Reinisch, G. Novacek, S. Riss, 2010, The American Journal of Gastroenterology.

6-Thioguanine Associated Nodular Regenerative Hyperplasia in Patients With Inflammatory Bowel Disease May Induce Portal Hypertension

F. Wrba, W. Reinisch, A. Gangl, 2007, The American Journal of Gastroenterology.

Prevalence and indicators of use of complementary and alternative medicine in Austrian patients with inflammatory bowel disease.

T. Waldhör, G. Novacek, H. Vogelsang, 2019, European journal of gastroenterology & hepatology.

The impact of intestinal resection on serum levels of anti‐Saccharomyces cerevisiae antibodies (ASCA) in patients with Crohn’s disease

W. Reinisch, C. Lichtenberger, G. Novacek, 2012, Alimentary pharmacology & therapeutics.

Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment

W. Reinisch, H. Lochs, A. Gangl, 2003, American Journal of Gastroenterology.

Severe ulcerative colitis complicated by an arterial thrombus in the brachiocephalic trunk.

M. Haumer, R. Koppensteiner, G. Novacek, 2007, Inflammatory bowel diseases.

Portal vein thrombosis in ulcerative colitis complicated by bleeding from gastric varices.

T. Rand, A. Gangl, M. Häfner, 2007, Inflammatory bowel diseases.

Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature.

W. Schima, M. Haumer, G. Novacek, 2004, Inflammatory bowel diseases.

A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis

H. Tilg, A. Kaser, P. Rutgeerts, 2003, Gut.

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn’s Disease: Report of the TOSCA Study

S. Vermeire, R. Ransohoff, R. Clare, 2017, Journal of Crohn's & colitis.

A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system

H. Vogelsang, U. Mellinger, T. Gräser, 2000, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Are inherited thrombotic risk factors associated with fibrostenosis in Crohn's disease?

W. Reinisch, C. Lichtenberger, R. Sunder-Plassmann, 2011, Inflammatory bowel diseases.

Healthy offspring in parents both receiving thiopurines.

W. Reinisch, H. Vogelsang, C. Dejaco, 2004, Gastroenterology.

Clinical presentation of venous thromboembolism in inflammatory

H. Tilg, A. Kaser, W. Petritsch, 2013 .

[Infliximab therapy for Crohn's disease - a practical guideline: actualised consensus of the working group for chronic inflammatory bowel diseases of the Austrian Society for Gastroenterology and Hepatology].

H. Tilg, A. Kaser, W. Petritsch, 2011, Zeitschrift fur Gastroenterologie.

Crohn ’ s Disease – a Practical Guideline : Actualised Consensus of the Working Group for Chronic Inflammatory Bowel Diseases of the Austrian Society for Gastroenterology and Hepatology

H. Tilg, A. Kaser, W. Petritsch, 2011 .

Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation

K. Turetschek, F. Wrba, H. Greinix, 2004, Annals of Hematology.

Impact of Different Therapeutic Regimens on the Outcome of Patients with Crohn’s Disease of the Upper Gastrointestinal Tract

A. Püspök, G. Oberhuber, H. Vogelsang, 2001, Inflammatory bowel diseases.

Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease.

M. Stolte, C. Zauner, F. Wrba, 1997, Gastroenterology.

Sonographic diagnosis of coeliac disease in a case with suspected acute liver failure.

F. Wrba, P. Ferenci, G. Novacek, 2005, European journal of gastroenterology & hepatology.

Severe Malabsorption due to Refractory Celiac Disease Complicated by Extensive Gastric Heterotopia of the Jejunum

A. Chott, G. Novacek, B. Tribl, 2004, The American journal of surgical pathology.

Atypical enteropathogenic E. coli are associated with disease activity in ulcerative colitis

C. Gasche, D. Mertens, C. Herbold, 2022, Gut microbes.

Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease

H. Vogelsang, N. Worel, G. Leitner, 2012, Transfusion Medicine and Hemotherapy.

[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].

H. Tilg, W. Petritsch, W. Reinisch, 2004, Zeitschrift fur Gastroenterologie.

A combined biochemical, biophysical and immunological approach towards the identification of celiac disease-specific wheat antigens

R. Valenta, I. Swoboda, H. Vogelsang, 2013, Amino Acids.

Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C

P. Ferenci, G. Novacek, H. Vogelsang, 2008, Alimentary pharmacology & therapeutics.

Safety and efficacy of endoscopic balloon dilation for treatment of Crohn's disease strictures.

W. Reinisch, A. Gangl, A. Püspök, 2006, Endoscopy.

No evidence of activated blood coagulation in Crohn's disease

A. Gangl, G. Novacek, W. Speiser, 1997, European journal of gastroenterology & hepatology.

A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis.

M. Schwab, W. Reinisch, E. Schaeffeler, 2005, Scandinavian journal of gastroenterology.

High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease.

W. Reinisch, W. Mayr, G. Novacek, 2012, The American journal of medicine.

Intestinal permeability and the prediction of relapse in Crohri's disease

H. Lochs, J. Wyatt, H. Vogelsang, 1993, The Lancet.

Long-term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to thiopurines.

W. Reinisch, A. Gangl, G. Novacek, 2010, Journal of Crohn's & colitis.

[Nutrition and IBD-Consensus of the Austrian Working Group of IBD (Inflammatory Bowel Diseases) of the ÖGGH].

W. Reinisch, H. Vogelsang, A. Mayer, 2014, Zeitschrift fur Gastroenterologie.

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.

H. Tilg, A. Kaser, W. Petritsch, 2010, Journal of Crohn's & colitis.

Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

S. Brand, J. Glas, M. Friedrich, 2013, Gut.

Infliximab or Cyclosporine as Rescue Therapy in Hospitalized Patients with Steroid‐Refractory Ulcerative Colitis: A Retrospective Observational Study

P. Hellström, W. Reinisch, J. Halfvarson, 2012, Inflammatory bowel diseases.

[Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].

W. Reinisch, A. Gangl, G. Novacek, 1998, Wiener klinische Wochenschrift.

Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongue

P. Ferenci, A. Gangl, A. Püspök, 2003, American Journal of Gastroenterology.

Withdrawal of Long-Term Maintenance Treatment with Azathioprine Tends to Increase Relapse Risk in Patients with Crohn’s Disease

W. Petritsch, W. Reinisch, G. Novacek, 2015, Digestive Diseases and Sciences.

Allogeneic expanded adipose‐derived stem cells in the treatment of rectovaginal fistulas in Crohn’s disease

W. Reinisch, S. Riss, A. Stift, 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Platelets Toll‐like receptor‐4 in Crohns disease

G. Novacek, H. Vogelsang, W. Schmid, 2017, European journal of clinical investigation.

Exocrine pancreatic dysfunction in sepsis

W. Sibbald, C. Madl, S. Spitzauer, 2003, European journal of clinical investigation.

Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults.

H. Vogelsang, G. Leitner, 2016, World journal of gastrointestinal pharmacology and therapeutics.

Exocrine pancreatic function in critically ill patients: Septic shock versus non‐septic patients

C. Madl, B. Schneider, S. Spitzauer, 2000, Critical care medicine.

Are single measurements of pseudocholinesterase and albumin markers for inflammatory activity or nutritional status in Crohn's disease?

H. Lochs, G. Novacek, H. Vogelsang, 1993, Wiener klinische Wochenschrift.

Whipple's disease: comparison of histology with diagnosis based on polymerase chain reaction in four consecutive cases.

F. Wrba, P. Schnider, H. Vogelsang, 1997, Gut.

Diagnostic duodenal bulb biopsy in celiac disease.

G. Oberhuber, H. Vogelsang, S. Hänel, 2001, Endoscopy.

Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study

F. Mascart, M. Mearin, K. Kaukinen, 2005, European journal of gastroenterology & hepatology.

Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study

O. Haas, A. Chott, G. Amann, 2014, BMC Gastroenterology.

In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease

G. Oberhuber, G. Granditsch, H. Vogelsang, 1999, American Journal of Gastroenterology.

Prevalence and clinical importance of hypertransaminasaemia in coeliac disease.

E. Penner, F. Wrba, P. Ferenci, 1999, European journal of gastroenterology & hepatology.

High proportion of granzyme B-positive (activated) intraepithelial and lamina propria lymphocytes in lymphocytic gastritis.

M. Stolte, G. Oberhuber, H. Vogelsang, 1998, The American journal of surgical pathology.

[Effect of a lactose-free diet on irritable bowel syndrome].

P. Ferenci, A. Gangl, H. Vogelsang, 1993, Wiener klinische Wochenschrift.

Factors impacting the results of interferon‐&ggr; release assay and tuberculin skin test in routine screening for latent tuberculosis in patients with inflammatory bowel diseases

W. Reinisch, G. Novacek, H. Vogelsang, 2011, Inflammatory bowel diseases.

Steroid dependency in Crohn's disease

W. Reinisch, H. Lochs, J. Wyatt, 1995, The Lancet.

Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding.

W. Reinisch, G. Novacek, H. Vogelsang, 2011, Journal of Crohn's & colitis.

Endoscopy and MR enteroclysis: Equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection

J. Fletcher, K. Turetschek, W. Schima, 2010, Inflammatory bowel diseases.

Short‐term complications of wide‐lumen stapled anastomosis after ileocolic resection for Crohn’s disease: who is at risk?

M. Mittlböck, I. Kristo, S. Riss, 2010, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis

H. Eichler, C. Schrolnberger, M. Brunner, 2005, Alimentary pharmacology & therapeutics.

Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's disease.

W. Reinisch, A. Gangl, T. Waldhör, 2006, World journal of gastroenterology.

[Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the OGGH].

H. Tilg, W. Petritsch, W. Reinisch, 2006, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.

Distribution of HLA Class I Alleles Differs in Celiac Disease Patients According to Age of Onset

W. Mayr, G. Fischer, G. Granditsch, 2003, Digestive Diseases and Sciences.

Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet

R. Valenta, M. Neurath, R. Atreya, 2015, The Journal of allergy and clinical immunology.

Complications in Crohn's disease: right-sided ureteric stenosis and hydronephrosis.

W. Schima, W. Reinisch, A. Gangl, 2007, Inflammatory bowel diseases.

G. Sachs, D. Genser, H. Lochs, 1995, European journal of gastroenterology & hepatology.

Transglutaminases as diagnostically relevant autoantigens in patients with gluten sensitivity

B. Volc-Platzer, G. Stingl, H. Vogelsang, 2005, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

Lymphocytic gastritis and gastric permeability in patients with celiac disease.

J. Wyatt, G. Oberhuber, H. Vogelsang, 1996, Gastroenterology.

Role of fecal calprotection in predicting endoscopic recurrence in postoperative Crohn’s disease

W. Reinisch, G. Novacek, H. Vogelsang, 2021, Scandinavian journal of gastroenterology.

Colorectal carcinoma and preceding fistula in Crohn's disease.

A. Sobala, G. Novacek, H. Vogelsang, 2010, Journal of Crohn's & colitis.

Sexual function and quality of life after surgical treatment for anal fistulas in Crohn’s disease

M. Mittlböck, W. Reinisch, S. Riss, 2013, Techniques in Coloproctology.

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.

Teck Kiang Tan, J. Mansfield, Fraser Cummings, 2021, The lancet. Gastroenterology & hepatology.

Letter: refractory coeliac disease and coeliac‐specific serology status – authors’ reply

H. Vogelsang, W. Eigner, 2017, Alimentary pharmacology & therapeutics.

W1138 A Nationwide Multicenter Study On Venous Thromboembolism in Inflammatory Bowel Disease

H. Tilg, A. Kaser, W. Petritsch, 2008 .

Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease.

G. Novacek, H. Vogelsang, W. Schmid, 2014, Journal of Crohn's & colitis.

Acupuncture has a Placebo Effect on Rectal Perception but not on Distensibility and Spatial Summation: A Study in Health and IBS

N. Talley, H. Hammer, H. Vogelsang, 2004, American Journal of Gastroenterology.

25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency.

P. Ferenci, A. Gangl, H. Vogelsang, 1997, Wiener klinische Wochenschrift.

Dietary vitamin D intake in patients with Crohn's disease.

P. Ferenci, H. Resch, H. Vogelsang, 1995, Wiener klinische Wochenschrift.

An open‐label trial of the selective cyclo‐oxygenase‐2 inhibitor, rofecoxib, in inflammatory bowel disease‐associated peripheral arthritis and arthralgia

W. Reinisch, C. Lichtenberger, H. Vogelsang, 2003, Alimentary pharmacology & therapeutics.

Plummer-Vinson syndrome associated with celiac disease and complicated by postcricoid carcinoma and carcinoma of the tongue.

P. Ferenci, A. Gangl, A. Püspök, 2003 .

Whipple's disease: comparison ofhistology with diagnosis based onpolymerase chain reaction in fourconsecutive cases

H. Vogelsang, D. Petermann, H. Riemer, 2011 .

Enteroclysis in adult celiac disease: diagnostic value of specific radiographic features

A. Kaider, K. Turetschek, W. Schima, 2003, European Radiology.

Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine)

C. Marosi, T. Brodowicz, C. Wenzel, 2002, Cancer Chemotherapy and Pharmacology.

Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.

T. Hibi, G. D'Haens, M. Ferrante, 2022, Gastroenterology.

P352 Is diagnostic delay associated with the risk of colectomy in patients with ulcerative colitis? Results of a study of the Austrian IBD study group

T. Waldhör, G. Novacek, H. Vogelsang, 2018 .

Steroid dependency in Crohn's disease.

W. Reinisch, H. Vogelsang, 2002, Gastroenterology.

Public awareness of Crohn's disease and ulcerative colitis: A national survey.

W. Reinisch, A. Gangl, G. Novacek, 2009, Journal of Crohn's & colitis.

Humoral response to COVID-19 infection in immunosuppressed patients with inflammatory bowel disease

H. Vogelsang, L. Weseslindtner, C. Primas, 2021, European journal of gastroenterology & hepatology.

[Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group "chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and Hepatology].

H. Tilg, A. Kaser, W. Petritsch, 2009, Zeitschrift fur Gastroenterologie.

[Use of infliximab in ulcerative colitis].

H. Tilg, W. Petritsch, W. Reinisch, 2007, Zeitschrift fur Gastroenterologie.

Budesonide in glucocorticoid dependent chronic active Crohn's disease; a pilot study.

H. Lochs, M. Kleinberger, G. Novacek, 1995, Zeitschrift fur Gastroenterologie.

[Therapy of active Crohn disease with Boswellia serrata extract H 15].

R. Repges, H. Vogelsang, F. Seifert, 2001, Zeitschrift fur Gastroenterologie.

Do changes in intestinal permeability predict disease relapse in Crohn's disease?

H. Vogelsang, 2008, Inflammatory bowel diseases.

Which patients with IBD need psychological interventions? A controlled study

W. Reinisch, A. Gangl, T. Stamm, 2008, Inflammatory bowel diseases.

Changes in Gastrointestinal Permeability in Celiac Disease

G. Oberhuber, H. Vogelsang, M. Schwarzenhofer, 1998, Digestive Diseases.

[Diagnosis and therapy of celiac disease in adolescence and adulthood].

G. Granditsch, H. Vogelsang, A. Propst, 2002, Zeitschrift fur Gastroenterologie.

In vivo and in vitro permeability in coeliac disease

J. Wyatt, G. Oberhuber, H. Vogelsang, 2001, Alimentary pharmacology & therapeutics.

Screening for celiac disease in first-degree relatives of patients with celiac disease by lactulose/mannitol test.

E. Penner, H. Lochs, J. Wyatt, 1995, The American journal of gastroenterology.

Characterization of sensations induced by capsaicin in the upper gastrointestinal tract

H. Vogelsang, J. Hammer, Johann Hammer, 2007, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Prospective evaluation of interferon-alpha in treatment of chronic active Crohn's disease.

W. Reinisch, H. Lochs, A. Gangl, 1995, Digestive diseases and sciences.

A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

W. Reinisch, G. Novacek, H. Vogelsang, 2015, Scandinavian journal of gastroenterology.

Safety and efficacy of granulocyte colony stimulating factor (G-CSF) for treatment of severe endoscopic postoperative recurrence in Crohn's disease (CD)

W. Reinisch, A. Gangl, C. Gasche, 2000 .

S0881 Therapeutic Drug Monitoring Dosing Regimen With Adalimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the SERENE-UC Maintenance Study

G. D'Haens, M. Ferrante, L. Peyrin-Biroulet, 2020 .

Influence of Helicobacter pylori infection on the phenotype of Crohn's disease.

A. Püspök, T. Waldhör, C. Gasche, 1999 .

Folate absorption in Crohn's disease.

G. Steger, R. Mader, P. Ferenci, 1994, Digestion.

Increased gastric and intestinal permeability in patients with Crohn's disease.

H. Lochs, J. Wyatt, A. Püspök, 1997, The American journal of gastroenterology.

Sucrose permeability as a marker for NSAID-induced gastroduodenal injury.

J. Smolen, J. Wyatt, W. Graninger, 1998, Clinical and experimental rheumatology.

A placebo‐controlled trial of an oral capsaicin load in patients with functional dyspepsia

H. Vogelsang, J. Hammer, M. Führer, 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Changes in blood rheology caused by Crohn's disease

D. Genser, A. Gangl, R. Koppensteiner, 1996, European journal of gastroenterology & hepatology.

Re: Celiac sprue: another autoimmune syndrome associated with hepatitis C

H. Vogelsang, A. Teml, 2001, American Journal of Gastroenterology.

Clinical and Immunologic Features of Ultra-Short Celiac Disease.

G. Oberhuber, H. Vogelsang, 2016, Gastroenterology.

Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease.

K. Turetschek, B. Schneider, A. Gangl, 1998, Endoscopy.

Treatment of peripheral arthropathy in IBD with rofecoxib, a selective COX-2 inhibitor

W. Reinisch, H. Vogelsang, C. Dejaco, 2001 .

Anti-TNF antibody in Crohn's disease--status of information, comments and recommendations of an international working group.

H. Tilg, M. Zeitz, E. Hahn, 1999, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.